Ensayo clínico

Randomized Double-Blind Trial on Safety and Efficacy of Nanordica Advanced Antibacterial Wound Dressing for Diabetic Foot Ulcer

NCT: NCT06667752 · ACTIVE_NOT_RECRUITING

ID NCTNCT06667752

EstadoACTIVE_NOT_RECRUITING

Fecha de inicio2024-10-17

Finalización2026-12-31

SponsorNanordica Medical OU (INDUSTRY)

First posted2024-10-31

Last updated2026-09-18

Resumen breve

This clinical trial evaluates the safety and efficacy of the Nanordica Advanced Antibacterial Wound Dressing (AAWD) in patients suffering from diabetic foot ulcers. At least 136 participants will be randomly allocated to be treated either with AAWD or Aquacel Ag+ Extra wound dressing for a 4-week active phase (intervention) followed by an 8-week standard of care period.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.